Suppr超能文献

越南南部卵巢交界性肿瘤的复发率及相关因素

Recurrence rate and associated factors of borderline ovarian tumors in the south of Vietnam.

作者信息

Vo Tuan M, Duong Kim A, Tran Ly T-H, Bui Thanh C

机构信息

Department of Obstetrics and Gynecology, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.

Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.

出版信息

J Obstet Gynaecol Res. 2019 Oct;45(10):2055-2061. doi: 10.1111/jog.14072. Epub 2019 Jul 31.

Abstract

AIM

This study aimed to determine the recurrence rate and related risk factors of borderline ovarian tumors (BOT).

METHODS

We conducted a retrospective cohort study with 433 patients who were surgically treated for primary BOT at Tu Du Hospital from 11/2008 to 09/2015. We used the life table method to estimate the cumulative recurrence rate. We used the log-rank test and Cox proportional hazard model to determine recurrence-associated factors.

RESULTS

Median follow-up time was 43 months (range: 3-105 months). Eighteen patients developed recurrence. The cumulative BOT recurrence rates at year 1, 2, 3 and 4 were 1.2% (95% confidence interval [CI] = 0.5-2.8), 3.0% (95% CI = 1.7-5.2), 4.6% (95% CI = 2.9-7.4), and 5.1% (95% CI = 3.2-8.0), respectively. In the final multivariate model, a higher recurrence rate was significantly associated with primary tumor stages (stage I vs stages II and III, hazards ratio [HR] = 4.44, 95% CI = 1.60-12.38), pre-operative tumor's capsule rupture (HR = 4.14, 95% CI = 1.78-9.64), and cystectomy (HR = 5.33, 95% CI = 1.43-19.91).

CONCLUSION

The overall BOT recurrence rate in women in southern Vietnam was moderate. Primary tumor stage, capsule rupture, and cystectomy were main factors associated with BOT recurrence. Appropriate follow-up strategies for patients with high-risk factors are needed for early detection and management of recurrence.

摘要

目的

本研究旨在确定卵巢交界性肿瘤(BOT)的复发率及相关危险因素。

方法

我们进行了一项回顾性队列研究,纳入了2008年11月至2015年9月在图度医院接受原发性BOT手术治疗的433例患者。我们采用寿命表法估计累积复发率。我们使用对数秩检验和Cox比例风险模型来确定复发相关因素。

结果

中位随访时间为43个月(范围:3 - 105个月)。18例患者出现复发。第1、2、3和4年的BOT累积复发率分别为1.2%(95%置信区间[CI]=0.5 - 2.8)、3.0%(95% CI = 1.7 - 5.2)、4.6%(95% CI = 2.9 - 7.4)和5.1%(95% CI = 3.2 - 8.0)。在最终的多变量模型中,较高的复发率与原发性肿瘤分期(I期与II期和III期相比,风险比[HR]=4.44,95% CI = 1.60 - 12.38)、术前肿瘤包膜破裂(HR = 4.14,95% CI = 1.78 - 9.64)以及囊肿切除术(HR = 5.33,95% CI = 1.43 - 19.91)显著相关。

结论

越南南部女性BOT的总体复发率适中。原发性肿瘤分期、包膜破裂和囊肿切除术是与BOT复发相关的主要因素。需要对具有高危因素的患者采取适当的随访策略,以便早期发现和处理复发情况。

相似文献

1
Recurrence rate and associated factors of borderline ovarian tumors in the south of Vietnam.
J Obstet Gynaecol Res. 2019 Oct;45(10):2055-2061. doi: 10.1111/jog.14072. Epub 2019 Jul 31.
3
Borderline Ovarian Tumors: Fifteen Years' Experience at a Scottish Tertiary Cancer Center.
Int J Gynecol Cancer. 2018 Nov;28(9):1683-1691. doi: 10.1097/IGC.0000000000001364.
4
[Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Epidemiological Aspects and Risk Factors].
Gynecol Obstet Fertil Senol. 2020 Mar;48(3):239-247. doi: 10.1016/j.gofs.2020.01.012. Epub 2020 Jan 28.
5
Prognostic factors predicting recurrence in borderline ovarian tumors.
Gynecol Oncol. 2009 Aug;114(2):237-41. doi: 10.1016/j.ygyno.2009.05.018. Epub 2009 May 29.
6
What is the impact of stromal microinvasion on oncologic outcomes in borderline ovarian tumors? A multicenter case-control study.
Arch Gynecol Obstet. 2017 Nov;296(5):979-987. doi: 10.1007/s00404-017-4496-4. Epub 2017 Sep 2.
7
Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.
Eur J Cancer. 2015 Mar;51(5):620-31. doi: 10.1016/j.ejca.2015.01.004. Epub 2015 Feb 3.
8
Risk factors for recurrence of borderline ovarian tumors in France: A multicenter retrospective study by the FRANCOGYN group.
J Gynecol Obstet Hum Reprod. 2021 Apr;50(4):101961. doi: 10.1016/j.jogoh.2020.101961. Epub 2020 Oct 28.

引用本文的文献

本文引用的文献

3
Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria.
Virchows Arch. 2017 Feb;470(2):125-142. doi: 10.1007/s00428-016-2040-8. Epub 2016 Dec 27.
5
Management of borderline ovarian tumors.
Ann Oncol. 2016 Apr;27 Suppl 1:i20-i22. doi: 10.1093/annonc/mdw090.
6
Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses.
Cochrane Database Syst Rev. 2016 Mar 1;3(3):CD010360. doi: 10.1002/14651858.CD010360.pub2.
7
Controversies in borderline ovarian tumors.
J Gynecol Oncol. 2015 Oct;26(4):343-9. doi: 10.3802/jgo.2015.26.4.343. Epub 2015 Sep 23.
8
Epithelial borderline ovarian tumor: Diagnosis and treatment strategy.
Obstet Gynecol Sci. 2015 May;58(3):183-7. doi: 10.5468/ogs.2015.58.3.183. Epub 2015 May 19.
9
Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group.
Eur J Cancer. 2013 May;49(8):1905-14. doi: 10.1016/j.ejca.2013.01.035. Epub 2013 Mar 13.
10
Diagnosis, treatment, and follow-up of borderline ovarian tumors.
Oncologist. 2012;17(12):1515-33. doi: 10.1634/theoncologist.2012-0139. Epub 2012 Sep 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验